Compound Info
NAs Base Info
ID Cluster Name Target MolWt
Compound Structure
NAs.001014 2
Target name Tax id
Adenosine A2 receptor 9606.0
Adenosine A2a receptor 9606.0
Phosphoglycerate kinase 9606.0
Adenosine A2b receptor 9606.0
Adenosine receptors; A1 & A3 9606.0
Adenosine receptor A2a and A3 9606.0
Heat shock protein HSP 90-alpha 9606.0
Adenosine receptors; A1 & A2 9606.0
Endoplasmin 9606.0
Adenosine A1 receptor 9606.0
Adenosine A3 receptor 9606.0
447.495
Chemical Representations
InChI InChI=1S/C24H25N5O4/c30-12-18-20(31)21(32)24(33-18)29-14-28-19-22(26-13-27-23(19)29)25-11-17(15-7-3-1-4-8-15)16-9-5-2-6-10-16/h1-10,13-14,17-18,20-21,24,30-32H,11-12H2,(H,25,26,27)/t18-,20-,21-,24-/m1/s1
InChI Key TUGMXIURLRAWSS-UMCMBGNQSA-N
SMILES OC[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)ncnc32)[C@H](O)[C@@H]1O
Molecular Formula C24H25N5O4
Functional Fragments
Base Ribose Phosphate
Base Structure
Unmatch
No Image Available
Match
Calculated Properties
logP 1.682 Computed by RDKit
Heavy Atom Count 33 Computed by RDKit
Ring Count 5 Computed by RDKit
Hydrogen Bond Acceptor Count 9 Computed by RDKit
Hydrogen Bond Donor Count 4 Computed by RDKit
Rotatable Bond Count 7 Computed by RDKit
Topological Polar Surface Area 125.550 Computed by RDKit
Activity Data
Target Activity type Relation Value Unit Assay Source
Adenosine A1 receptor Ki = 6.8 nM Inhibition of binding of [3H]N6-cyclohexyladenosine to adenosine A1 receptor of rat whole brain membranes. CHEMBL1124694
Adenosine A2 receptor Ki = 25.0 nM Inhibition of binding of [3H]NECA to adenosine A2 receptor of rat striatal membranes. CHEMBL1124694
Adenosine receptors; A1 & A2 Ratio = 3.6 Selectivity ratio for A1 receptor to that of A2 receptor in vitro in rat tissues CHEMBL1124694
Phosphoglycerate kinase IC50 nM Inhibition of Trypanosoma brucei phosphoglycerate kinase (PGK); inactive at 4 mM CHEMBL1133593
Adenosine A1 receptor Ki = 6.8 nM Binding affinity to adenosine A1 receptor in rat whole brain membranes by [3H]N6-cyclohexyladenosine displacement. CHEMBL1123600
Adenosine A2 receptor Ki = 25.0 nM Binding affinity to A2 adenosine receptor in rat striatal membranes by [3H]NECA (1-(6-amino-9H-purin-9-yl)-1-deoxy-N-ethyl-beta-D-ribofuranuronamide) displacement. CHEMBL1123600
Mus musculus ED50 = 1.3 mg.kg-1 Effect on Motor activity in mouse following i.p. administration. CHEMBL1123600
Mus musculus ED50 = 145.0 mg.kg-1 Effect on Ataxia in mouse following i.p. administration. CHEMBL1123600
Rattus norvegicus ED50 = 2.2 mg.kg-1 Effect on Motor activity(MA) in rat was measured as ED50 by perorally administration of compound. CHEMBL1123600
Rattus norvegicus ED50 = 31.0 mg.kg-1 Effect on Ataxia(ATX) in rat was measured as ED50 by perorally administration of compound. CHEMBL1123600
Rattus norvegicus ED50 = 2.5 mg.kg-1 Effect on Sidman conditioned avoidance in rat. CHEMBL1123600
Adenosine A1 receptor Ki = 6.8 nM Binding affinity at adenosine A1 receptor from rat brain membranes by [3H]N6-cyclohexyladenosine displacement. CHEMBL1124142
Adenosine A2 receptor Ki = 25.0 nM Binding affinity at adenosine A2 receptor from rat striatal membranes by [3H]NECA displacement. CHEMBL1124142
Adenosine receptors; A1 & A2 Ratio = 3.61 Ratio of binding affinity against A2 and A1 receptors CHEMBL1124142
Adenosine A1 receptor Ki = 6.8 nM Binding affinity towards adenosine A1 receptor on rat whole brain membrane using [3H]N6-cyclohexyladenosine CHEMBL1124304
Adenosine A2 receptor Ki = 25.0 nM Binding affinity towards adenosine A2 receptor on rat striatal membrane using [3H]NECA as radioligand CHEMBL1124304
Adenosine A1 receptor EC25 = 90.0 nM Reduction of heart rate (A1 response) in isolated rat heart preparation CHEMBL1124304
Adenosine A2 receptor EC25 = 10.0 nM Enhancement of coronary flow (A2 response) in isolated rat heart preparation CHEMBL1124304
Adenosine receptors; A1 & A2 Ratio = 3.7 Ratio of Ki at adenosine A2 and A1 receptors CHEMBL1124304
Adenosine A1 receptor Ki = 6.8 nM Binding affinity against adenosine A1 receptor using [3H]-CHA or [3H]PIA as radioligand CHEMBL1125572
Adenosine A2 receptor Ratio = 25.0 nM Binding affinity against adenosine A2 receptor using [3H]- NECA as radioligand CHEMBL1125572
Adenosine receptors; A1 & A2 Ratio = 3.7 Ratio of A2 to A1. CHEMBL1125572
ADMET k' = 8.29 Index of hydrophobicity (k') CHEMBL1123294
Adenosine A2 receptor Activity = 30.8 M g-1 Binding affinity against A2 adenosine receptor CHEMBL1123294
Adenosine A2 receptor K = 83775.0 M-1 Association constant against A2 adenosine receptor CHEMBL1123294
Adenosine A2 receptor MPR = 0.71 Molar potency ratio (MPR) against adenosine A2 receptor of canine coronary artery CHEMBL1123294
Adenosine A1 receptor Ki = 50.0 nM Inhibition of [3H]R-PIA binding to human Adenosine A1 receptor expressed in CHO cells CHEMBL1142719
Adenosine A2a receptor Ki = 510.0 nM Inhibition of [3H]-CGS- 21680 binding to human Adenosine A2A receptor expressed in CHO cells CHEMBL1142719
Adenosine A2b receptor Activation = 70.0 % Relative activation of human Adenosine A2B receptor at 10 uM treatment compared to 10 uM Cl-IB-MECA CHEMBL1142719
Adenosine A3 receptor Ki = 3.9 nM Inhibition of [125I]-AB-MECA binding to human Adenosine A3 receptor expressed in CHO cells CHEMBL1142719
Adenosine A3 receptor Activation = 0.0 % Relative activation of human Adenosine A3 receptor expressed in CHO cells at 10 uM treatment compared to 10 uM Cl-IB-MECA CHEMBL1142719
Adenosine A3 receptor Ki = 540.0 nM Inhibition of [125I]AB-MECA binding to rat Adenosine A3 receptor expressed in CHO cells CHEMBL1142719
Adenosine A2a receptor Ki = 49.9 nM Binding affinity to A2A adenosine receptor CHEMBL1949672
Adenosine A3 receptor IC50 Antagonist activity at human adenosine A3 receptor expressed in CHO cells assessed as blockade of Cl-IB-MECA-mediated inhibition of forskolin-stimulated [3H]cAMP accumulation by scintillation counter CHEMBL2177029
Adenosine A3 receptor Ki = 538.0 nM Displacement of [125I]I-AB-MECA from human rat adenosine A3 receptor expressed in CHO cells after 60 mins by gamma counter CHEMBL2177029
Adenosine A2a receptor Ki = 510.0 nM Displacement of [3H]CGS21680 from human recombinant adenosine A2A receptor expressed in CHO cells after 60 mins by gamma counter CHEMBL2177029
Unchecked Ratio Ki = 131.0 Selectivity ratio of Ki for human recombinant adenosine A2A receptor to Ki for human recombinant adenosine A3 receptor expressed in CHO cells CHEMBL2177029
Adenosine A2a receptor Ki = 75.0 nM Displacement of [3H]CGS21680 from rat adenosine A2A receptor expressed in CHO cells after 60 mins by gamma counter CHEMBL2177029
Adenosine A1 receptor Ki = 50.0 nM Displacement of [3H]CCPA from human recombinant adenosine A1 receptor expressed in CHO cells after 60 mins by gamma counter CHEMBL2177029
Adenosine A1 receptor Ki = 44.0 nM Displacement of [3H]CCPA from rat adenosine A1 receptor expressed in CHO cells after 60 mins by gamma counter CHEMBL2177029
Adenosine receptors; A1 & A3 Ratio Ki = 12.8 Selectivity ratio of Ki for human recombinant adenosine A1 receptor to Ki for human recombinant adenosine A3 receptor expressed in CHO cells CHEMBL2177029
Unchecked Ratio Ki = 12.0 Selectivity ratio of Ki for rat adenosine A1 receptor to Ki for rat adenosine A3 receptor expressed in CHO cells CHEMBL2177029
Adenosine receptor A2a and A3 Ratio Ki = 7.2 Selectivity ratio of Ki for rat adenosine A2A receptor to Ki for rat adenosine A3 receptor expressed in CHO cells CHEMBL2177029
Adenosine A3 receptor Ki = 3.9 nM Displacement of [125I]I-AB-MECA from human recombinant adenosine A3 receptor expressed in CHO cells after 60 mins by gamma counter CHEMBL2177029
Endoplasmin Activity Displacement of FITC-geldanamycin from GRP94 (unknown origin) at 50 uM after 24 hrs by fluorescence polarization assay relative to control CHEMBL4680372
Heat shock protein HSP 90-alpha Activity Displacement of FITC-geldanamycin from HSP90alpha (unknown origin) at 50 uM after 24 hrs by fluorescence polarization assay relative to control CHEMBL4680372
A549 Activity = 77.0 % Antimigratory activity in human A549 cells assessed as wound closure at 2.5 uM after 24 hrs by scratch wound healing assay (Rvb = 59 %) CHEMBL4680372
A549 Activity = 91.0 % Antimigratory activity in human A549 cells assessed as wound closure at 2.5 uM after 36 hrs by scratch wound healing assay (Rvb = 88 %) CHEMBL4680372
MDA-MB-231 Activity = 62.0 % Antimigratory activity in human MDA-MB-231 cells assessed as wound closure at 2.5 uM after 24 hrs by scratch wound healing assay (Rvb = 64 %) CHEMBL4680372
MDA-MB-231 Activity = 90.0 % Antimigratory activity in human MDA-MB-231 cells assessed as wound closure at 2.5 uM after 48 hrs by scratch wound healing assay (Rvb = 93 %) CHEMBL4680372
MDA-MB-231 Activity Antimigratory activity in human MDA-MB-231 cells assessed as rate of wound closure at 20 uM after 24 hrs by scratch wound healing assay CHEMBL4680372
MDA-MB-231 Activity Antimigratory activity in human MDA-MB-231 cells assessed as rate of wound closure at 20 uM after 48 hrs by scratch wound healing assay CHEMBL4680372
Adenosine A1 receptor Ki = 49.9 nM Displacement of [3H]R-PIA from recombinant human A1AR measured after 60 mins by liquid scintillation counting method CHEMBL4680372
Adenosine A2a receptor Ki = 510.0 nM Displacement of [3H]CGS21680 from recombinant human A2AR measured after 60 mins by liquid scintillation counting method CHEMBL4680372
Unchecked Ki = 3.9 nM Displacement of [125I]-AB-MECA from human A3AR expressed in CHO cells measured after 60 mins by liquid scintillation counting method CHEMBL4680372
Adenosine A2b receptor EC50 = 485.0 nM Agonist activity at recombinant human A2BAR expressed in CHO cells assessed as stimulation of cAMP formation preincubated for 30 mins in presence of rolipram and adenosine deaminase followed by compound addition and measured after 20 mins by alphascreen cAMP assay CHEMBL4680372